SecBot SecBot
144 ·Filed Aug 3, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001628280-26-051952
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, small-dollar director sale with no material impact. Monitor for any larger insider sales or changes in the company's commercial trajectory for ZORYVE, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$26.03
T+0 close · Aug 3, 2026 · via day close
Latest settled
+21.71%
T+60 · $31.68
Vs SPY
+21.33%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 4 $26.03entry
  2. T+1 · 3mo ago +4.11%α +4.31% · $27.10
  3. T+5 · 3mo ago +0.77%α +0.87% · $26.23
  4. T+20 · 3mo ago −8.76%α −7.52% · $23.75
  5. T+60 · 20d ago +21.71%α +21.33% · $31.68
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Patrick Burnett filed a Form 144 notice of intent to sell 955 shares of Arcutis Biotherapeutics common stock, valued at approximately $24,942. This is a small, routine sale by a director, representing a tiny fraction of the company's $3.4B market cap. The filing is neutral as it signals a planned sale but lacks material size or urgency, and no cross-filing context is present to escalate its significance.

Key Facts

  • Director Patrick Burnett filed a Form 144 to sell 955 shares of ARQT common stock.
  • Estimated sale value is approximately $24,942 based on the filing date.
  • The shares were acquired via restricted stock vesting on August 1, 2026.
  • Burnett has sold 906 shares in two prior transactions in May 2026, totaling ~$20,823.
  • The sale represents less than 0.001% of Arcutis's $3.4B market cap.

Financial Impact

Director intends to sell 955 shares worth ~$24,942, a de minimis amount relative to the company's $3.4B market cap.

dilution

Risk Factors

  • No material risk identified from this filing; the sale is small and routine.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-051952
Document: 0001628280-26-051952-index.html0001628280-26-051952
Document: 0001628280-26-051952.txt0001628280-26-051952

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (10h 21m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 3, 2026